Australia markets open in 9 hours 45 minutes

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.6700+0.0200 (+0.75%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 37.64M
Enterprise value -55.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)64.69
Price/book (mrq)0.42
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-65.23%
S&P500 52-week change 326.27%
52-week high 37.7250
52-week low 31.6700
50-day moving average 32.5143
200-day moving average 33.0513

Share statistics

Avg vol (3-month) 399.22k
Avg vol (10-day) 345.88k
Shares outstanding 514.1M
Implied shares outstanding 614.92M
Float 89.59M
% held by insiders 18.43%
% held by institutions 157.55%
Shares short (30 Apr 2024) 481.96k
Short ratio (30 Apr 2024) 40.94
Short % of float (30 Apr 2024) 40.59%
Short % of shares outstanding (30 Apr 2024) 40.58%
Shares short (prior month 28 Mar 2024) 485.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:18
Last split date 313 Feb 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-7,530.61%

Management effectiveness

Return on assets (ttm)-30.29%
Return on equity (ttm)-51.91%

Income statement

Revenue (ttm)423k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-1.00%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-28.65M
Diluted EPS (ttm)-2.7200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)85.95M
Total cash per share (mrq)6.01
Total debt (mrq)180k
Total debt/equity (mrq)0.22%
Current ratio (mrq)13.02
Book value per share (mrq)5.83

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A